07:31 AM EDT, 03/16/2026 (MT Newswires) -- Olema Pharmaceuticals ( OLMA ) reported Monday a Q4 net loss of $0.50 per diluted share, narrower than a loss of $0.51 a year earlier.
Analysts polled by FactSet expected a loss of $0.51.
As of Dec. 31, Olema said it had cash, cash equivalents, and marketable securities of $505.4 million.